Home > For Consumers > Conditions and Diseases > Communicable Diseases Information > Influenza

Influenza

Composition of Australian Influenza Vaccine for the 2013 season

This page contains information on the recommended influenza vaccine for the Southern Hemisphere winter 2013.

The Australian Influenza Vaccine Committee (AIVC) met on 3 October 2012, and agreed to adopt the September WHO recommendations.

The Committee decided that the influenza vaccine components for the 2013 season should contain the following:

• A (H1N1): an A/California/7/2009 (H1N1) - like virus, 15 µg HA per dose
• A (H3N2): an A/Victoria/361/2011 (H3N2) - like virus, 15 µg HA per dose
• B: a B/Wisconsin/1/2010 - like virus, 15 µg HA per dose

The Therapeutic Goods Administration (TGA) considers the reassortants or viruses listed on the WHO Influenza vaccine viruses and reagents web pages, as suitable vaccine strains for H1N1, H3N2 and B-Yamagata/16/88 lineage viruses.

If other candidate vaccine viruses become available, their suitability for use should be discussed with the TGA by emailing Influenza Standards.